Overview of pharmacoeconomic modelling methods
MetadataShow full item record
In the current climate of burgeoning health care costs, pharmacoeconomics is becoming increasingly important, but knowledge about pharmacoeconomic methods is limited among most clinicians. This review provides an introduction to, and overview of, common methods used in pharmacoeconomic modelling: decision analysis, Markov modelling, discounting and uncertainty analyses via Monte Carlo simulation. It will conclude with a suggested approach to reading and appraising published pharmacoeconomic analyses. © 2012 The British Pharmacological Society.
Showing items related by title, author, creator and subject.
Alawadhi, Sohaila (2010)Background: According to the United Kingdom prospective diabetes study, metformin is considered the drug of choice in overweight newly diagnosed type 2 diabetic patients. Metformin is well characterized as a substrate of ...
Wlodarczyk, J.; Reid, Christopher; Pater, G. (2011)Objectives: Bosentan, a dual endothelin receptor antagonist (ERA), was the first oral drug approved for the treatment of pulmonary arterial hypertension (PAH), a rare disease with poor prognosis. In 2004 the Australian ...
Sustained 3-Year Benefits in Quality of Life After Percutaneous Coronary Interventions in the Elderly: A Prospective Cohort StudyYan, B.; Chan, L.; Lee, V.; Yu, C.; Wong, M.; Sanderson, J.; Reid, Christopher (2017)© 2017 International Society for Pharmacoeconomics and Outcomes Research (ISPOR). Background: Impact of percutaneous coronary interventions (PCI) on health-related quality of life (HRQOL) is important but under-reported ...